| P50 | author | Jinxia Liu | Q88253958 |
| P2093 | author name string | Wei Zhang | |
| | Feng Jiang | |
| | Shiqing Zhang | |
| | Yihui Fan | |
| | Runzhou Ni | |
| | Jingxin Zhang | |
| | Wenkai Ni | |
| | Cuihua Lu | |
| | Lishuai Qu | |
| | Mingbing Xiao | |
| | Saiyan Bian | |
| | Chenzhou Xu | |
| P2860 | cites work | Mdm2 induces mono-ubiquitination of FOXO4 | Q21092186 |
| | Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom) | Q24301672 |
| | The ubiquitin-specific protease USP28 is required for MYC stability | Q24308568 |
| | Emerging trends in hepatocellular carcinoma incidence and mortality | Q27334932 |
| | Structure of USP7 catalytic domain and three Ubl-domains reveals a connector α-helix with regulatory role | Q27704874 |
| | High-resolution profiling of histone methylations in the human genome | Q27860906 |
| | OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3 | Q28513798 |
| | Methylation of histone H3 Lys 4 in coding regions of active genes | Q29614680 |
| | Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway | Q30415089 |
| | Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. | Q34107531 |
| | Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives | Q34701416 |
| | HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma | Q37387937 |
| | A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells | Q37389377 |
| | USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis | Q37577477 |
| | CDDO-Me reveals USP7 as a novel target in ovarian cancer cells | Q37718344 |
| | Chemotherapy for hepatocellular carcinoma: The present and the future | Q38639762 |
| | Strategies to optimize siRNA delivery to hepatocellular carcinoma cells. | Q38713376 |
| | USP7 promotes cell proliferation through the stabilization of Ki-67 protein in non-small cell lung cancer cells | Q39426487 |
| | Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells | Q39813804 |
| | Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating IL-8 expression | Q40147252 |
| | MicroRNA-205 regulates ubiquitin specific peptidase 7 protein expression in hepatocellular carcinoma cells | Q40780673 |
| | Reactivating nuclear PTEN to treat CLL. | Q42335075 |
| | Spatial distribution of di- and tri-methyl lysine 36 of histone H3 at active genes | Q46370672 |
| | Targeting HAUSP in both p53 wildtype and p53-mutant tumors. | Q52332504 |
| | Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. | Q53225430 |
| | Clinical Significance of Ubiquitin Specific Protease 7 (USP7) in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms. | Q54957789 |
| | Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma. | Q54977194 |
| | Systemic Therapy for Hepatocellular Carcinoma: Latest Advances | Q58093758 |
| | Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma | Q58699656 |
| | Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases | Q59357734 |
| | Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator | Q60918251 |
| | Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in wild-type Ewing sarcoma | Q61570969 |
| | USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia | Q61816131 |
| | Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis | Q64389021 |
| | Ubiquitin-based anticancer therapy: carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors | Q84174712 |
| | Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF-κB signaling pathway in multiple myeloma | Q90339903 |
| | Ubiquitin‑specific protease 7 promotes osteosarcoma cell metastasis by inducing epithelial‑mesenchymal transition | Q90443572 |
| | Cancer statistics, 2019 | Q90941571 |
| | Targeting the overexpressed USP7 inhibits esophageal squamous cell carcinoma cell growth by inducing NOXA-mediated apoptosis | Q91292445 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 28 | |
| P577 | publication date | 2020-01-28 | |
| P1433 | published in | Cancer Cell International | Q1829859 |
| P1476 | title | Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance | |
| P478 | volume | 20 | |